BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2540565)

  • 1. DHPG (Gancyclovir) improves survival in CMV pneumonia.
    Mai M; Nery J; Sutker W; Husberg B; Klintmalm G; Gonwa T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2263-5. PubMed ID: 2540565
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive cytomegalovirus pneumonia and myocarditis in a renal transplant recipient: successful treatment with DHPG.
    Shabtai M; Luft B; Waltzer WC; Anaise D; Rapaport FT
    Transplant Proc; 1988 Jun; 20(3):562-3. PubMed ID: 2837853
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG).
    Watson FS; O'Connell JB; Amber IJ; Renlund DG; Classen D; Johnston JM; Smith CB; Bristow MR
    J Heart Transplant; 1988; 7(2):102-5. PubMed ID: 2835468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
    Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
    Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHPG treatment of kidney transplant recipients with severe CMV infection.
    Lang P; Buisson C; Rostoker G; Ben Maadi A; Fruchaud G; Deforge L; Chopin D; Abbou C; Romano P; Fleury J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2084-6. PubMed ID: 2540560
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
    Stoffel M; Pirson Y; Squifflet JP; Lamy M; Gianello P; Alexandre GP
    Transpl Int; 1988 Dec; 1(4):181-5. PubMed ID: 2855305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
    de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation.
    Stein DS; Verano AS; Levandowski RA
    Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine.
    Selby P; Powles RL; Jameson B; Stolle K; Tryhorn Y; Stern H
    Lancet; 1986 Jun; 1(8494):1377-8. PubMed ID: 2872484
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients.
    D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Jun; 21(3):3560-1. PubMed ID: 2545018
    [No Abstract]   [Full Text] [Related]  

  • 13. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.
    Winston DJ; Ho WG; Bartoni K; Holland GN; Mitsuyasu RT; Gale RP; Busuttil RW; Champlin RE
    Rev Infect Dis; 1988; 10 Suppl 3():S547-53. PubMed ID: 2847292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
    Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
    JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection in patients with AIDS.
    Drew WL
    J Infect Dis; 1988 Aug; 158(2):449-56. PubMed ID: 2841381
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine.
    Cantarovich M; Hiesse C; Lantz O; Fassi-Fihri S; Charpentier B; Fries D
    Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of cytomegalovirus pneumonia.
    Crumpacker C; Marlowe S; Zhang JL; Abrams S; Watkins P
    Rev Infect Dis; 1988; 10 Suppl 3():S538-46. PubMed ID: 2847291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report.
    Icenogle TB; Peterson E; Ray G; Minnich L; Copeland JG
    J Heart Transplant; 1987; 6(4):199-203. PubMed ID: 2822880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
    Aulitzky WE; Tilg H; Niederwieser D; Hackl M; Meister B; Huber C
    J Infect Dis; 1988 Aug; 158(2):488-9. PubMed ID: 2841384
    [No Abstract]   [Full Text] [Related]  

  • 20. Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.
    Hecht DW; Snydman DR; Crumpacker CS; Werner BG; Heinze-Lacey B
    J Infect Dis; 1988 Jan; 157(1):187-90. PubMed ID: 2826608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.